The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to ...

The generic medicine industry of India is unlikely to be impacted by United States president Donald Trump's decision to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General ...

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

Equity benchmarks tumble as IT stocks lead decline despite easing geopolitical tensions, with markets opening lower.

The BSE Sensex witnessed sharp profit-booking in Tuesday’s session, dragged down by heavyweight IT stocks. The index declined ...

The Nifty Pharma index closed on a positive note on Tuesday. Shares of Ajanta Pharma Ltd.(up 4.45 per cent), Granules India ...

The BSE Sensex tumbled 1,281.68 points, or 1.5%, to close at 81,148.22 levels, and the NSE Nifty50 settled at 24,578.35, down ...

US President Donald Trump's new 'Most Favored Nation' policy for prescription drugs may pose significant challenges for India ...

On May 13, 2025, the domestic markets witnessed a sharp decline, with the BSE Sensex dropping 1.55 per cent to close at ...

Markets end in red after yesterday's rally and highest ever single-day jump in Nifty; IT and FMCG were top losers in today's trade ...

India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its ...

Indian stock markets saw notable declines on Tuesday due to profit-booking following Monday's surge, driven by eased Indo-Pak ...